• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Edgewell Personal Care Company

    3/19/26 4:31:06 PM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $EPC alert in real time by email
    S-8 1 epc-formsx8.htm S-8 Document
    As filed with the Securities and Exchange Commission on March 19, 2026
    Registration No. 333-
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM S-8
    REGISTRATION STATEMENT
    UNDER THE SECURITIES ACT OF 1933

     EDGEWELL PERSONAL CARE COMPANY
    (Exact name of registrant as specified in its charter)
    ______________________________________________________________________________________________________
    Missouri
     
    43-1863181
    (State or other jurisdiction of
    incorporation or organization)
     
    (I.R.S. Employer
    Identification No.)
    6 Research Drive,
    Shelton, CT
     
    06484
    (Address of Principal Executive Offices)
     
    (Zip Code)
    EDGEWELL PERSONAL CARE COMPANY
    3RD AMENDED AND RESTATED 2018 STOCK INCENTIVE PLAN
    (Full Title of the Plan)

    Francesca Weissman
    Chief Financial Officer
    EDGEWELL PERSONAL CARE COMPANY
    6 Research Drive
    Shelton, Connecticut 06484
    (203) 944-5500
    (Name, address, and telephone number, including area code, of agent for service)

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

    Large accelerated filer Accelerated filer ☐
    Non-accelerated filer Smaller reporting company☐
    Emerging growth company☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.




    EXPLANATORY NOTE

    Unless the context otherwise requires, references made herein to “Edgewell,” “the Company,” “Registrant,” “we,” “us,” “our” and “ours” refer to Edgewell Personal Care Company and its consolidated subsidiaries.
    3rd Amended and Restated 2018 Stock Incentive Plan
    On November 5, 2025, the Company’s Board of Directors adopted the Edgewell Personal Care Company 3rd Amended and Restated 2018 Stock Incentive Plan (the “3rd A&R 2018 Plan”), subject to shareholder approval. On February 5, 2026, the Company’s shareholders approved the adoption of the 3rd A&R 2018 Plan. The 3rd A&R 2018 Plan amends and restates the Company’s 2nd Amended and Restated 2018 Stock Incentive Plan (the “2nd A&R 2018 Plan”) and includes an additional 2,100,000 shares of Common Stock, $0.01 par value per share (the “Common Stock”), of the Company available for grant and issuance, plus the number of remaining shares of Common Stock not issued or subject to outstanding grants under the 2nd A&R 2018 Plan on February 5, 2026, plus any shares of Common Stock that are subject to awards granted under the 2nd A&R 2018 Plan that expire, are forfeited or canceled or terminate for any other reason after February 6, 2020 without the issuance of shares. This Registration Statement on Form S-8 registers an additional 2,300,000 shares of Common Stock available for grant and issuance under the 3rd A&R 2018 Plan, which includes the 2,100,000 newly authorized additional shares of Common Stock available for issuance under such plan and an estimated 200,000 shares of Common Stock that have or may become available under such plan pursuant to the share recycling provision.
    Pursuant to General Instruction E to Form S-8, this Registration Statement on Form S-8 incorporates the contents of the Registration Statement on Form S-8 previously filed by the Company with the Securities and Exchange Commission (“SEC”) on February 24, 2023 (File No. 333-270027).





    Part I
    INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS


    Item 1.    Plan Information.
    Not required to be filed with this Registration Statement.

    Item 2.    Registrant Information and Employee Plan Annual Information.
    Not required to be filed with this Registration Statement.



    Part II
    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
    Item 3. Incorporation of Documents by Reference.
    The following documents listed in (a) through (e) below, which are on file with the SEC, are incorporated herein by reference (except for the portions of the Company’s Current Reports on Form 8-K furnished pursuant to Item 2.02 or Item 7.01 thereof or otherwise not filed with the SEC which are deemed not to be incorporated by reference into this Registration Statement):
    (a)The Company’s Annual Report on Form 10-K for the year ended September 30, 2025, filed with the SEC on November 18, 2025 (including information specifically incorporated by reference therein from the Company’s definitive proxy statement on Schedule 14A filed with the SEC on December 22, 2025);
    (b)The Company’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2025, filed with the SEC on February 9, 2026;
    (c)The Company’s Current Report on Form 8-K, filed with the SEC on November 13, 2025;
    (d)The Company’s Current Report on Form 8-K, filed with the SEC on February 6, 2026 (only with respect to Item 2.01 and Exhibits 2.1 and 99.2);
    (e)The Company’s Current Report on Form 8-K, filed with the SEC on February 9, 2026 (only with respect to Items 5.02 and 5.07 and Exhibit 10.1); and
    (f)The description of the Company’s Common Stock contained in its Registration Statement on Amendment No. 3 to Form 10, dated March 16, 2000, as updated by Exhibit 4.1 to the Company’s Annual Report on Form 10-K for the year ended September 30, 2025 as well as any other amendments or reports filed for the purpose of updating such description.
    All documents filed by the Company with the SEC pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) subsequent to the date hereof and prior to the filing of a post-effective amendment hereto which indicates that all securities offered hereunder have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part hereof from the date of filing of such documents except that the portion of any Current Report on Form 8-K furnished pursuant to Item 2.02 or Item 7.01 thereof shall not be incorporated by reference herein.
    For purposes of this Registration Statement, any statement contained in a document incorporated or deemed to be incorporated herein by reference shall be deemed to be modified or superseded to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated herein by reference modifies or supersedes such statement in such document. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement. 

    Item 4. Description of Securities.
    Not applicable.

    Item 5. Interests of Named Experts and Counsel.
    Not applicable.

    Item 6. Indemnification of Directors and Officers.
    The Company is a Missouri corporation. Section 351.355.1 of the Missouri General and Business Corporation Law (the “MGBCL”) provides, in general, that a corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, other than an action by or in the right of the corporation, by reason of the fact that he or she is or was a director, officer, employee or agent of the corporation or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses, including attorneys’ fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action, suit or proceeding if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. The termination of any action, suit, or proceeding by judgment, order,



    settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that his or her conduct was unlawful.
    Section 351.355.2 of the MGBCL provides, in general, that a corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that he or she is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses, including attorneys' fees, and amounts paid in settlement actually and reasonably incurred by him or her in connection with the defense or settlement of the action or suit if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation; except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable for negligence or misconduct in the performance of his or her duty to the corporation, unless and only to the extent that the court in which the action or suit was brought determines upon application that, despite the adjudication of liability and in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for expenses which the court shall deem proper.
    Section 351.355.3 of the MGBCL provides that, except as otherwise provided in the corporation’s articles of incorporation or the bylaws, to the extent a director, officer, employee or agent of the corporation has been successful on the merits or otherwise in the defense of any action, suit or proceeding referred to Section 351.355.1 or 351.355.2 of the MGBCL, or in defense of any claim, issue or matter therein, he or she shall be indemnified against expenses, including attorneys’ fees, actually and reasonably incurred by him or her in connection with the action, suit or proceeding.
    Section 351.355.5 of the MGBCL provides that expenses incurred in defending any civil, criminal, administrative or investigative action, suit, or proceeding may be paid by the corporation in advance of the final disposition of the action, suit, or proceeding as authorized by the board of directors in the specific case upon receipt of an undertaking by or on behalf of the director, officer, employee or agent to repay such amount unless it shall ultimately be determined that he or she is entitled to be indemnified by the corporation as authorized in that section.
    Section 351.355.6 of the MGBCL further provides that any person who is or was a director, officer, employee or agent, or any person who is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, is entitled to seek indemnification under any applicable articles of incorporation, bylaw, agreement, vote of shareholders or disinterested directors or otherwise.
    Section 351.355.8 of the MGBCL provides, in general, that a corporation may purchase and maintain insurance or another arrangement on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against him or her and incurred by him or her in any such capacity, or arising out of his or her status as such, whether or not the corporation would have the power to indemnify him or her against such liability under the provisions of the law.
    Section 351.055.2(3) of the MGBCL permits a corporation to include in its articles of incorporation a provision eliminating or limiting the personal liability of a director to the corporation or its shareholders for monetary damages for breach of fiduciary duty as a director, provided that such provision shall not eliminate or limit the liability of a director (i) for any breach of the director’s duty of loyalty to the corporation or its shareholders, (ii) for acts or omissions not in subjective good faith or which involve intentional misconduct or a knowing violation of law, (iii) pursuant to Section 351.345 of the MGBCL or (iv) for any transaction from which the director derived an improper personal benefit.
    The Company’s amended and restated articles of incorporation, as amended (the “articles of incorporation”), generally provides that the Company shall indemnify each person (other than a party plaintiff suing on his or her own behalf or in the right of the Company) who at any time is serving or has served as a director, officer or employee of the Company against any claim, liability or expense incurred as a result of such service, to the maximum extent permitted by law. The articles of incorporation also require the Company to indemnify any such person against expenses (including, without limitation, costs of investigation and attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action, suit or proceeding. In addition, the articles of incorporation provide that the Company may, if it deems appropriate, indemnify any person (other than a party plaintiff suing on his or her own behalf or in the right of the Company) who at any time is serving or has served as an agent of the Company against any claim, liability or expense incurred as a result of such service, or as a result of any other service on behalf of the Company, or service at the request of the Company as a director, officer, employee, member or agent of another corporation, partnership, joint venture, trust, trade or industry association, or other enterprise (whether incorporated or unincorporated, for-profit or not-for-profit), to the maximum extent permitted by law or to such lesser extent as the Company, in its discretion, may deem appropriate. Without limiting the



    generality of the foregoing, under the articles of incorporation, the Company may indemnify any such person (other than a party plaintiff suing on his or her own behalf or in the right of the Company), who was or is a party, or is threatened to be made a party, to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (including, but not limited to, an action by or in the right of the Company) by reason of such service, against expenses (including, without limitation, costs of investigation and attorneys' fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action, suit or proceeding.
    The articles of incorporation provide that the liability of the Company’s directors, officers and employees to the Company, its shareholders or otherwise is limited to the fullest extent permitted by the MGBCL. Consequently, should the MGBCL or any other applicable law be amended or adopted hereafter so as to permit the elimination or limitation of such liability, the liability of the directors, officers, or employees of the Company shall be so eliminated or limited without the need for amendment to the articles of incorporation or further action on the part of the Company’s shareholders.
    As permitted by Section 351.355.7 of the MGBCL and as authorized by the articles of incorporation, the Company has entered into customary indemnification contracts with its directors. Pursuant to those agreements, the Company has agreed to indemnify the directors to the full extent authorized or permitted by the MGBCL. The agreements also provide for the advancement of expenses of defending any civil or criminal action, claim, suit or proceeding against the director and for repayment of such expenses by the director if it is ultimately judicially determined that the director is not entitled to such indemnification.
    As permitted by Section 351.355.8 of the MGBCL and as authorized by the articles of incorporation, the Company has purchased directors’ and officers’ insurance, which protects each director and officer from liability for actions taken in their capacity as directors or officers. This insurance may provide broader coverage for such individuals than may be required by the provisions of the articles of incorporation.
    The foregoing represents a summary of the general effect of the indemnification provisions of the MGBCL, the articles of incorporation and such agreements and insurance as noted. Additional information regarding indemnification of directors and officers can be found in Section 351.355 of the MGBCL, the articles of incorporation and any pertinent agreements.

    Item 7. Exemption from Registration Claimed.
    Not applicable.




    Item 8. Exhibits.
    Exhibit Number
    Description
    4.1
    Amended and Restated Articles of Incorporation of the Company (which is incorporated by reference to Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2013, filed on January 30, 2014).
    4.2
    Articles of Merger effective June 30, 2015 (which is incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on July 1, 2015).


    4.3
    Amended and Restated Bylaws of the Company effective November 5, 2020 (which is incorporated by reference to Exhibit 3.3 to the Company’s Annual Report on Form 10-K for the year ended September 30, 2021, filed on November 19, 2021).


    5.1#
    Opinion of Stinson LLP.

    23.1#
    Consent of PricewaterhouseCoopers LLP.
    23.2#
    Consent of Stinson LLP (included in Exhibit 5.1).

    24.1#
    Power of Attorney (contained on the page following the signature page hereto).


    99.1
    Edgewell Personal Care 3rd Amended and Restated 2018 Stock Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on February 9, 2026).


    107#
    Filing fee table.
     # Filed herewith.

    Item 9. Undertakings.
    (a)    The undersigned Registrant hereby undertakes;
    (1)    To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
    (i)    To include any prospectus required by Section 10(a)(3) of the Securities Act;
    (ii)    To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and
    (iii)    To include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement.
    Provided, however, that the undertakings set forth in paragraphs (a)(1)(i) and (a)(1)(ii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement;
    (2)    That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; and
    (3)    To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
    (b)    The undersigned Registrant hereby further undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) under the Exchange Act), that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the



    securities offered therein, and the offering of such securities at the time shall be deemed to be the initial bona fide offering thereof.
    (c)    Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.





    SIGNATURES
    Pursuant to the requirements of the Securities Act, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Town of Shelton, State of Connecticut, on March 19, 2026.

    EDGEWELL PERSONAL CARE COMPANY
    By:/s/ Francesca Weissman
     Francesca Weissman
     Chief Financial Officer




    POWER OF ATTORNEY
    KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Francesca Weissman and LaTanya Langley, and any one or more of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place, and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement and any additional registration statements pursuant to Rule 462(b) of the Securities Act, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the SEC, and hereby grants to such attorneys-in-fact and agents, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
    Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.
    Signature
      
    Title
     
    Date
    /s/ Rod R. Little
      
    Chief Executive Officer and Director
    (Principal Executive Officer)
     
    March 19, 2026
    Rod R. Little
      
     
    /s/ Francesca Weissman
      
    Chief Financial Officer
    (Principal Financial Officer)
     
    March 19, 2026
    Francesca Weissman
      
     
    /s/ John Dunham
      
    Chief Accounting Officer
    (Principal Accounting Officer)
     
    March 19, 2026
    John Dunham
      
     
    /s/ Robert W. Black
    Director
     
    March 19, 2026
    Robert W. Black
      
     
    /s/ George R. Corbin
      
    Director
     
    March 19, 2026
    George R. Corbin
      
     
    /s/ Carla C. Hendra
      
    Director
     
    March 19, 2026
    Carla C. Hendra
      
     
    /s/ John C. Hunter, III
      
    Non-Executive Chairman of the Board
     
    March 19, 2026
    John C. Hunter, III
      
     
    /s/ Rakesh Sachdev

    Director

    March 19, 2026
    Rakesh Sachdev



    /s/ Stephanie Stahl

    Director

    March 19, 2026
    Stephanie Stahl



    /s/ Swan Sit
                                             Director
    March 19, 2026
    Swan Sit




    March 19, 2026
    /s/ Gary Waring

    Director

    Gary Waring





    Get the next $EPC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EPC

    DatePrice TargetRatingAnalyst
    8/6/2025$23.00Underweight → Equal-Weight
    Morgan Stanley
    2/8/2024$39.00Underweight → Equal Weight
    Barclays
    4/5/2023$47.00Neutral
    UBS
    11/17/2022$48.00Buy
    Canaccord Genuity
    10/26/2022$47.00 → $42.00Buy → Neutral
    Goldman
    10/17/2022$40.00 → $36.00Equal-Weight → Underweight
    Morgan Stanley
    2/10/2022$46.00 → $43.00Equal-Weight
    Morgan Stanley
    2/9/2022$55.00 → $47.00Overweight
    Wells Fargo
    More analyst ratings

    $EPC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Edgewell Personal Care to Webcast Fireside Chat at the 47th Annual Raymond James Institutional Investors Conference

    SHELTON, Conn., Feb. 27, 2026 /PRNewswire/ -- Edgewell Personal Care Company (NYSE:EPC) today announced that it will participate in a fireside chat at the 47th Annual Raymond James Institutional Investors Conference in Orlando, FL on Wednesday March 4, 2026, at 8:40 A.M. ET.  Rod Little, President and Chief Executive Officer and Francesca Weissman, Chief Financial Officer will be presenting for Edgewell. All interested parties may access a live webcast of these events at www.edgewell.com, under "Investors," and "News and Events" tabs or by using the following link:  http://ir.ed

    2/27/26 12:32:00 PM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    Edgewell Personal Care Announces First Quarter Fiscal 2026 Results

    Q1 performance ahead of expectations for Sales, Adjusted EPS and EBITDA Successfully Completed Feminine Care Business Divestiture for $340 Million, Sharpening Portfolio Focus Full Year Outlook for Continuing Operations Remains Consistent with Prior Outlook SHELTON, Conn., Feb. 9, 2026 /PRNewswire/ -- Edgewell Personal Care Company (NYSE:EPC) today announced results for its first fiscal quarter 2026 ended December 31, 2025.  "We delivered a solid start to fiscal 2026. Our first quarter performance modestly exceeded our expectations for organic net sales, adjusted EPS and adjus

    2/9/26 6:00:00 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    Edgewell Personal Care Completes the Sale of its Feminine Care Business to Essity for $340M

    SHELTON, Conn., Feb. 2, 2026 /PRNewswire/ -- Edgewell Personal Care Company (NYSE:EPC) today announced that it has completed the sale of its feminine care business to Essity, a leading global health and hygiene company based in Sweden, for $340 million. Edgewell intends to use the net proceeds from the sale, after taxes and transaction costs, primarily to strengthen its balance sheet and pay down the balance of U.S. revolving credit facility while continuing to invest in the long-term growth of its core businesses. "Completing the sale of our Feminine Care business is a pivota

    2/2/26 12:16:00 PM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    $EPC
    SEC Filings

    View All

    SEC Form S-8 filed by Edgewell Personal Care Company

    S-8 - EDGEWELL PERSONAL CARE Co (0001096752) (Filer)

    3/19/26 4:31:06 PM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by Edgewell Personal Care Company

    SCHEDULE 13G/A - EDGEWELL PERSONAL CARE Co (0001096752) (Subject)

    2/12/26 5:17:21 PM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 10-Q filed by Edgewell Personal Care Company

    10-Q - EDGEWELL PERSONAL CARE Co (0001096752) (Filer)

    2/9/26 1:35:34 PM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    $EPC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Sit Swan

    4 - EDGEWELL PERSONAL CARE Co (0001096752) (Issuer)

    2/9/26 10:50:21 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 4 filed by Director Sachdev Rakesh

    4 - EDGEWELL PERSONAL CARE Co (0001096752) (Issuer)

    2/9/26 10:49:26 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 4 filed by Director Stahl Stephanie

    4 - EDGEWELL PERSONAL CARE Co (0001096752) (Issuer)

    2/9/26 10:48:33 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    $EPC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Edgewell Personal Care upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Edgewell Personal Care from Underweight to Equal-Weight and set a new price target of $23.00

    8/6/25 7:51:55 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    Edgewell Personal Care upgraded by Barclays with a new price target

    Barclays upgraded Edgewell Personal Care from Underweight to Equal Weight and set a new price target of $39.00

    2/8/24 6:30:53 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    UBS initiated coverage on Edgewell Personal Care with a new price target

    UBS initiated coverage of Edgewell Personal Care with a rating of Neutral and set a new price target of $47.00

    4/5/23 8:58:06 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    $EPC
    Leadership Updates

    Live Leadership Updates

    View All

    Edgewell Personal Care Appoints Jessica Spence as President of North America Business

    SHELTON, Conn., Oct. 2, 2024 /PRNewswire/ -- Edgewell Personal Care Company (NYSE: EPC) is pleased to announce the appointment of Jessica Spence as President of its North America business, effective October 24, 2024. In this role, Spence will lead Edgewell's North American commercial business and will report directly to Rod Little, President and Chief Executive Officer. Edgewell's President and Chief Executive Officer, Rod Little commented, "We are thrilled to welcome Jessica to our team. Jessica is a seasoned and accomplished leader with an impressive brand-building and opera

    10/2/24 10:27:00 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    Edgewell Personal Care Appoints Stephanie Stahl to Board of Directors

    SHELTON, Conn., Sept. 12, 2024 /PRNewswire/ -- Edgewell Personal Care Company (NYSE: EPC) announced that it has appointed Stephanie Stahl to its Board of Directors, effective September 10. Following her appointment, the Board will now include 11 members. As a consumer-driven and sustainability-focused business leader, brand builder, board member and advisor, Stahl has extensive marketing and strategy experience in high-growth, turnaround and early-stage operating environments. She also has significant business transformation, post-merger integration and public board leadership

    9/12/24 1:08:00 PM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    Edgewell Personal Care Announces Appointment of John Dunham as Chief Accounting Officer

    SHELTON, Conn., Feb. 23, 2024 /PRNewswire/ -- Edgewell Personal Care Company (NYSE:EPC) today announced the appointment of John Dunham as Chief Accounting Officer (CAO). Mr. Dunham will be based in the Company's Shelton, Connecticut office reporting to Dan Sullivan, Chief Financial Officer. "John is a seasoned accounting executive with over twenty years of broad-based technical and operational accounting experience. During his career, he has demonstrated a track record of success in improving operational accounting effectiveness and regulatory compliance as well as developing

    2/23/24 8:30:00 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    $EPC
    Financials

    Live finance-specific insights

    View All

    Edgewell Personal Care Announces First Quarter Fiscal 2026 Results

    Q1 performance ahead of expectations for Sales, Adjusted EPS and EBITDA Successfully Completed Feminine Care Business Divestiture for $340 Million, Sharpening Portfolio Focus Full Year Outlook for Continuing Operations Remains Consistent with Prior Outlook SHELTON, Conn., Feb. 9, 2026 /PRNewswire/ -- Edgewell Personal Care Company (NYSE:EPC) today announced results for its first fiscal quarter 2026 ended December 31, 2025.  "We delivered a solid start to fiscal 2026. Our first quarter performance modestly exceeded our expectations for organic net sales, adjusted EPS and adjus

    2/9/26 6:00:00 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    Edgewell Personal Care Company to Webcast a Discussion of First Quarter Fiscal Year 2026 Results on February 9, 2026

    SHELTON, Conn., Jan. 12, 2026 /PRNewswire/ -- Edgewell Personal Care Company (NYSE:EPC) will report its financial results for the first quarter fiscal year 2026 before the market opens on February 9, 2026. Edgewell will discuss its results during an investor conference call that will be webcast on February 9, 2026, beginning at 8:00 a.m. Eastern Time. The call will be hosted by President and Chief Executive Officer Rod Little and Chief Financial Officer Francesca Weissman. All interested parties may access a live webcast of this conference call at www.edgewell.com, under "Inve

    1/12/26 4:30:00 PM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    Edgewell Personal Care Announces Fourth Quarter and Fiscal 2025 Results; Provides 2026 Outlook

    Fourth Quarter Net Sales increased 3.8%, or 2.5% Organic increaseFiscal 2025 Net Sales decreased 1.3%, or 1.3% Organic decreaseFiscal 2025 GAAP EPS $0.53, Adjusted EPS $2.52 Returned $120 Million to Shareholders via Dividends and Share Repurchases for Fiscal Year 2025 SHELTON, Conn., Nov. 13, 2025 /PRNewswire/ -- Edgewell Personal Care Company (NYSE:EPC) today announced results for its fourth fiscal quarter 2025 and fiscal year ended September 30, 2025.  Executive Summary Fourth quarter net sales were $537.2 million, an increase of 3.8% compared to the prior year quarter. Ful

    11/13/25 6:00:00 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    $EPC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Edgewell Personal Care Company

    SC 13G/A - EDGEWELL PERSONAL CARE Co (0001096752) (Subject)

    11/8/24 10:55:54 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G/A filed by Edgewell Personal Care Company (Amendment)

    SC 13G/A - EDGEWELL PERSONAL CARE Co (0001096752) (Subject)

    2/13/24 5:04:49 PM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G/A filed by Edgewell Personal Care Company (Amendment)

    SC 13G/A - EDGEWELL PERSONAL CARE Co (0001096752) (Subject)

    2/12/24 11:09:25 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary